Dr. Yogesh Munot brings over 20 years of experience in drug discovery, CRO/CDMO services, and strategic client partnerships across global pharmaceutical and biotech industries.

He has a proven track record of leading integrated drug discovery programs and advancing multiple molecules from early discovery to clinical stages. His experience spans collaborations with global clients across the US, EU, and APAC regions, delivering high-quality solutions under FTE and FFS models.

Yogesh has held senior leadership roles at leading organizations including Enveda Biosciences, Laxai Life Sciences, Sai Life Sciences, GVK Biosciences, Advinus Therapeutics (a Tata Enterprise), Biocon Bristol-Myers Squibb Research Centre, and Nycomed Pharma. He has successfully managed cross-functional teams, driven R&D strategy, and strengthened long-term client relationships

His core expertise includes medicinal and synthetic chemistry, custom synthesis, process development, and scale-up of complex molecules, with deep experience in kinase inhibitors, GPCRs, and lipid-based drug discovery. He has contributed to advancing multiple programs into preclinical and clinical stages and has extensive experience in managing global collaborations.